Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke (AMASCIS-02)
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke. A Phase IIB Multicenter Double Blind Placebo Controlled Clinical Trial
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Listed as NCT04280003, this PHASE2 trial focuses on Adipose Tissue-derived Stem Cell and Functional Status and remains ongoing. Sponsored by Instituto de Investigación Hospital Universitario La Paz, it has been updated 12 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2023 — Jun 2024 [monthly]
Recruiting PHASE2
-
Jul 2022 — Jun 2023 [monthly]
Recruiting PHASE2
▶ Show 7 earlier versions
-
Sep 2021 — Jul 2022 [monthly]
Recruiting PHASE2
-
Feb 2021 — Sep 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto de Investigación Hospital Universitario La Paz
For direct contact, visit the study record on ClinicalTrials.gov .